Literature DB >> 22123668

New wrinkles in lipoprotein lipase biology.

Brandon S J Davies1, Anne P Beigneux, Loren G Fong, Stephen G Young.   

Abstract

PURPOSE OF REVIEW: We summarize recent progress on GPIHBP1, a molecule that transports lipoprotein lipase (LPL) to the capillary lumen, and discuss several newly studied molecules that appear important for the regulation of LPL activity. RECENT
FINDINGS: LPL, the enzyme responsible for the lipolytic processing of triglyceride-rich lipoproteins, interacts with multiple proteins and is regulated at multiple levels. Several regulators of LPL activity have been known for years and have been investigated thoroughly, but several have been identified only recently, including an endothelial cell protein that transports LPL to the capillary lumen, a microRNA that reduces LPL transcript levels, a sorting protein that targets LPL for uptake and degradation, and a transcription factor that increases the expression of apolipoproteins that regulate LPL activity.
SUMMARY: Proper regulation of LPL is important for controlling the delivery of lipid nutrients to tissues. Recent studies have identified GPIHBP1 as the molecule that transports LPL to the capillary lumen, and have also identified other molecules that are potentially important for regulating LPL activity. These new discoveries open new doors for understanding basic mechanisms of lipolysis and hyperlipidemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22123668      PMCID: PMC3383841          DOI: 10.1097/MOL.0b013e32834d0b33

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  57 in total

1.  Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

Authors:  H N Ginsberg; N A Le; I J Goldberg; J C Gibson; A Rubinstein; P Wang-Iverson; R Norum; W V Brown
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

2.  GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia.

Authors:  Sybil Charrière; Noël Peretti; Sophie Bernard; Mathilde Di Filippo; Agnès Sassolas; Micheline Merlin; Mireille Delay; Cyrille Debard; Etienne Lefai; Alain Lachaux; Philippe Moulin; Christophe Marçais
Journal:  J Clin Endocrinol Metab       Date:  2011-08-03       Impact factor: 5.958

Review 3.  Apolipoprotein C-II and lipoprotein lipase activity.

Authors:  A L Catapano
Journal:  Ric Clin Lab       Date:  1982 Jan-Mar

4.  The significance of lipoprotein lipase in rat skeletal muscles.

Authors:  M H Tan; T Sata; R J Havel
Journal:  J Lipid Res       Date:  1977-05       Impact factor: 5.922

5.  An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.

Authors:  L A Pennacchio; M Olivier; J A Hubacek; J C Cohen; D R Cox; J C Fruchart; R M Krauss; E M Rubin
Journal:  Science       Date:  2001-10-05       Impact factor: 47.728

6.  Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma.

Authors:  W J McConathy; P Alaupovic
Journal:  Biochemistry       Date:  1976-02-10       Impact factor: 3.162

7.  Evidence for rapid "metabolic switching" through lipoprotein lipase occupation of endothelial-binding sites.

Authors:  Thomas Pulinilkunnil; Ashraf Abrahani; Jospy Varghese; Nathan Chan; Irvin Tang; Sanjoy Ghosh; Jerze Kulpa; Michael Allard; Roger Brownsey; Brian Rodrigues
Journal:  J Mol Cell Cardiol       Date:  2003-09       Impact factor: 5.000

8.  ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.

Authors:  Tetsuya Shimizugawa; Mitsuru Ono; Mitsuru Shimamura; Kenichi Yoshida; Yosuke Ando; Ryuta Koishi; Kenjiro Ueda; Toshimori Inaba; Hiroyuki Minekura; Takafumi Kohama; Hidehiko Furukawa
Journal:  J Biol Chem       Date:  2002-07-03       Impact factor: 5.157

9.  Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II.

Authors:  P K Kinnunen; R L Jackson; L C Smith; A M Gotto; J T Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

10.  Lipoprotein lipase. Mechanism of product inhibition.

Authors:  G Bengtsson; T Olivecrona
Journal:  Eur J Biochem       Date:  1980-05
View more
  24 in total

1.  Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase.

Authors:  Terje Robal; Mikael Larsson; Miina Martin; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

2.  Disruption of the selenocysteine lyase-mediated selenium recycling pathway leads to metabolic syndrome in mice.

Authors:  Lucia A Seale; Ann C Hashimoto; Suguru Kurokawa; Christy L Gilman; Ali Seyedali; Frederick P Bellinger; Arjun V Raman; Marla J Berry
Journal:  Mol Cell Biol       Date:  2012-08-13       Impact factor: 4.272

3.  A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver.

Authors:  Aras N Mattis; Guisheng Song; Kelly Hitchner; Roy Y Kim; Andrew Y Lee; Amar D Sharma; Yann Malato; Michael T McManus; Christine C Esau; Erich Koller; Suneil Koliwad; Lee P Lim; Jacquelyn J Maher; Robert L Raffai; Holger Willenbring
Journal:  Hepatology       Date:  2014-11-24       Impact factor: 17.425

4.  The hepatic transcriptome of young suckling and aging intrauterine growth restricted male rats.

Authors:  William A Freije; Shanthie Thamotharan; Regina Lee; Bo-Chul Shin; Sherin U Devaskar
Journal:  J Cell Biochem       Date:  2015-04       Impact factor: 4.429

5.  Mechanism of hypertriglyceridemia in CTP:phosphoethanolamine cytidylyltransferase-deficient mice.

Authors:  Ratnesh Kumar Singh; Morgan D Fullerton; Donna Vine; Marica Bakovic
Journal:  J Lipid Res       Date:  2012-07-04       Impact factor: 5.922

6.  Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.

Authors:  Xun Chi; Shwetha K Shetty; Hannah W Shows; Alexander J Hjelmaas; Emily K Malcolm; Brandon S J Davies
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

7.  Syndecan-1 Mediates Sorting of Soluble Lipoprotein Lipase with Sphingomyelin-Rich Membrane in the Golgi Apparatus.

Authors:  Emma L Sundberg; Yongqiang Deng; Christopher G Burd
Journal:  Dev Cell       Date:  2019-09-19       Impact factor: 12.270

8.  Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells.

Authors:  Brandon S J Davies; Chris N Goulbourne; Richard H Barnes; Kirsten A Turlo; Peter Gin; Sue Vaughan; David J Vaux; André Bensadoun; Anne P Beigneux; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2012-09-24       Impact factor: 5.922

Review 9.  Novel aspects of brown adipose tissue biology.

Authors:  Joerg Heeren; Heike Münzberg
Journal:  Endocrinol Metab Clin North Am       Date:  2012-12-12       Impact factor: 4.741

10.  Severe hypertriglyceridemia in a newborn with monogenic lipoprotein lipase deficiency: an unconventional therapeutic approach with exchange transfusion.

Authors:  Lorenza Pugni; Enrica Riva; Carlo Pietrasanta; Claudio Rabacchi; Stefano Bertolini; Cristina Pederiva; Fabio Mosca; Sebastiano Calandra
Journal:  JIMD Rep       Date:  2013-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.